How to Come Up With Wild and Crazy Ideas
“”Imagination is more important than knowledge.” - Albert Einstein
“”Imagination is more important than knowledge.” - Albert Einstein
How does interdisciplinary research influence scholarship and scholarly careers?
Glasstree allows academics and their supporting institutions to actually profit from sales of their work.
Nordic nations dominate the top 15, while South Korea reigns supreme and Russia is dealt a huge blow.
Without an open source model, the world outside the technology sector will continue to struggle in its adoption of Artificial Intelligence & Machine Learning.
Proposals for the next Research Excellence Framework have so far produced a lively discussion.
Michael Eisen from University of California in Berkeley, California, registered the Twitter handle @SenatorPhD and declared his intention to run in the 2018 election for a seat in the United States Senate.
Poor monitoring in ‘second-tier’ institutions is also part of the problem, research indicates
The legends of mathematics that almost never were.
In the wake of the Flint water crisis and with a new notably anti-science president, U.S. scientists are reevaluating how to navigate the tension between speaking out and a fear of losing research funding.
And why should you care? There's a global trend of companies integrating hackathons into their overall innovation strategy.
A leading website that monitored predatory open access journals has closed. This will make it harder to keep tabs on this corrosive force within science.
Every single day new advancements are being made in the world of education, but when you look at the media and the people who are making these advancements, you rarely will see a black woman being honored.
For publishers, this moment of political upheaval has the potential to allow them to reboot their fraught relationships with libraries, universities, and scientists.
As United States and British legislators tighten the screws on travel and visa rules, they might be squeezing out international researchers and students. Canadian universities, meanwhile, are seeing surging interest from both groups.
The Trump administration has mounted a vigorous defense of its ban on travel from seven majority-Muslim nations, saying it is necessary to prevent terrorists from entering the United States. But the ban, now blocked by a federal judge, also ensnared travelers important to the well-being of many Americans: doctors.
Two University of Washington professors are taking aim at BS in a provocatively named new course they hope to teach this spring.
A road map for the founding entrepreneur who seeks to retain the CEO position as a company gains market traction and begins a period of rapid growth.
Very informative and In-depth annual open access roundup.
Replacing the real world with a virtual one is a neat trick. Combining the two could be more useful.
This is one of our biggest failures as a scientific community — we haven’t done a good job of actually communicating with people about what we do.
Bubbling beakers, blazing Bunsen burners, boiling broths and a book.
Universities are facing a crisis of relevance. While there are multiple reasons for this to be happening, one that deserves particular attention is the extent to which academic scholars do not see it as their role to engage in public and political discourse. However, increased engagement is unavoidable in an emerging educational context where the calibre of public discourse has become so degraded and social media is changing the nature of science and scientific discourse within society.
An overview of the new rules to consider where scientific projects include the processing of personal data.
The Scholix initiative is a high level interoperability framework for exchanging information about the links between scholarly literature and data.
Two countries vie to invest more of their economy into research than anyone else.
Each scientist and engineer chosen will receive an average of up to $300,000 per year for 5 years for life sciences research.
Nearly 100 founders and leaders of biotech companies express their deep concern and opposition to the executive order signed by President Donald Trump on January 27, 2017.